HRSA directs Sanofi to cease implementing unapproved 340B rebate proposal - American Hospital Ass...

HRSA directs Sanofi to cease implementing unapproved 340B rebate proposal  American Hospital Association

Sanofi pays SK bioscience €50M as children's pneumococcal vaccine enters phase 3 - Fierce Biotech

Sanofi pays SK bioscience €50M as children's pneumococcal vaccine enters phase 3  Fierce Biotech

The Zacks Analyst Blog Highlights ServiceNow, AMD, Sanofi, Team and United-Guardian - Yahoo Finance

The Zacks Analyst Blog Highlights ServiceNow, AMD, Sanofi, Team and United-Guardian  Yahoo Finance

Sanofi sues HHS to defend 340B rebate policy - Healthcare Dive

Sanofi sues HHS to defend 340B rebate policy  Healthcare Dive

Press Release: Sanofi initiates phase 3 program for PCV21 - GlobeNewswire

Press Release: Sanofi initiates phase 3 program for PCV21  GlobeNewswire

Our Global Manufacturing & Supply Network - Sanofi

Our Global Manufacturing & Supply Network  Sanofi

PDUFAs for Tonix and Nuvation; Sanofi vaccine partnership; RAPT allergy deal - Endpoints News

PDUFAs for Tonix and Nuvation; Sanofi vaccine partnership; RAPT allergy deal  Endpoints News

Sanofi, Teva say study results show gut disease drug could be ‘best in class’ - BioPharma Dive

Sanofi, Teva say study results show gut disease drug could be ‘best in class’  BioPharma Dive

Sanofi revenue 2006-2023 - Statista

Sanofi revenue 2006-2023  Statista

Aficamten attracts more interest as Sanofi buys China rights - The Pharma Letter

Aficamten attracts more interest as Sanofi buys China rights  The Pharma Letter

CEO of pharma giant Sanofi says businesses should stop ‘AI washing’ - Fortune

CEO of pharma giant Sanofi says businesses should stop ‘AI washing’  Fortune

Sanofi takes SK Bio-partnered pneumococcal shot into phase 3 - pharmaphorum

Sanofi takes SK Bio-partnered pneumococcal shot into phase 3  pharmaphorum

Why Is Sanofi (SNY) Among the Best European Dividend Stocks To Buy Now? - Yahoo Finance

Why Is Sanofi (SNY) Among the Best European Dividend Stocks To Buy Now?  Yahoo Finance

Partner Spotlight: AQEMIA and Sanofi Harness Generative AI and Deep Physics to Power R&D - Sanofi

Partner Spotlight: AQEMIA and Sanofi Harness Generative AI and Deep Physics to Power R&D  Sanofi

Sanofi joins J&J, Eli Lilly in proposing 340B rebate model - Healthcare Dive

Sanofi joins J&J, Eli Lilly in proposing 340B rebate model  Healthcare Dive

Sanofi scoops up China rights to Cytokinetics' heart disease med ahead of approval decision - Fie...

Sanofi scoops up China rights to Cytokinetics' heart disease med ahead of approval decision  Fierce Biotech

Sanofi net income 2007-2023 - Statista

Sanofi net income 2007-2023  Statista

SK bioscience and Sanofi expand agreement for pneumococcal conjugate vaccines - Yahoo Finance

SK bioscience and Sanofi expand agreement for pneumococcal conjugate vaccines  Yahoo Finance

Every Breath Matters: Addressing Unmet Needs in Respiratory Care - Sanofi

Every Breath Matters: Addressing Unmet Needs in Respiratory Care  Sanofi

Sanofi’s Tolebrutinib Receives FDA Breakthrough Therapy Designation for nrSPMS - Yahoo Finance

Sanofi’s Tolebrutinib Receives FDA Breakthrough Therapy Designation for nrSPMS  Yahoo Finance

Sanofi expands SK Bio deal, starts phase III of GBP-410 - BioWorld Online

Sanofi expands SK Bio deal, starts phase III of GBP-410  BioWorld Online

Sanofi and Orano join forces to develop next-generation radioligand medicines - orano.group

Sanofi and Orano join forces to develop next-generation radioligand medicines  orano.group

Sanofi expands SK bioscience deal for pneumococcal conjugate vaccines - The Pharma Letter

Sanofi expands SK bioscience deal for pneumococcal conjugate vaccines  The Pharma Letter

It’s Time to Look Beyond the Bleed - Sanofi

It’s Time to Look Beyond the Bleed  Sanofi

Sanofi 'surprised' by PAI Partners' raised bid for Opella unit - Reuters.com

Sanofi 'surprised' by PAI Partners' raised bid for Opella unit  Reuters.com

Resalis Therapeutics Gains Strategic Equity Investment from Sanofi - Business Wire

Resalis Therapeutics Gains Strategic Equity Investment from Sanofi  Business Wire

Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's - Investopedia

Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's  Investopedia

Sanofi expands collaboration with SK Bioscience - European Biotechnology News

Sanofi expands collaboration with SK Bioscience  European Biotechnology News

France seeks job guarantees from Sanofi over Doliprane painkiller production - Reuters.com

France seeks job guarantees from Sanofi over Doliprane painkiller production  Reuters.com

Sanofi workers in France to strike over sale of consumer health unit, union official says - Reuters

Sanofi workers in France to strike over sale of consumer health unit, union official says  Reuters

Teva and Sanofi Mid-Stage Data Reveal Shows Best-in-Class Potential for IBD Drug - MedCity News

Teva and Sanofi Mid-Stage Data Reveal Shows Best-in-Class Potential for IBD Drug  MedCity News

Sanofi employees 2009-2023 - Statista

Sanofi employees 2009-2023  Statista

Sanofi Beats Q3 Forecasts Fueled by 381% Growth in Beyfortus Sales - BioSpace

Sanofi Beats Q3 Forecasts Fueled by 381% Growth in Beyfortus Sales  BioSpace

Sanofi at COP28: supporting the decarbonization of healthcare systems - Sanofi

Sanofi at COP28: supporting the decarbonization of healthcare systems  Sanofi

CD&R nears deal to buy Sanofi's consumer unit for $16 bln, source says - Reuters.com

CD&R nears deal to buy Sanofi's consumer unit for $16 bln, source says  Reuters.com

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III - Zacks Investment Research

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III  Zacks Investment Research

Sanofi returns to Orano with €300M for new radioligand 'pioneer' - Fierce Biotech

Sanofi returns to Orano with €300M for new radioligand 'pioneer'  Fierce Biotech

Sanofi earnings boosted by Beyfortus, earlier vaccine sales - BioPharma Dive

Sanofi earnings boosted by Beyfortus, earlier vaccine sales  BioPharma Dive

Sanofi- Cell Research outstanding paper award of 2023 - Nature.com

Sanofi- Cell Research outstanding paper award of 2023  Nature.com

Sanofi plans to change hospital drug-discount program - Reuters.com

Sanofi plans to change hospital drug-discount program  Reuters.com

Sanofi Dips Into Red-Hot Radiopharma Space With $110M Licensing Deal - BioSpace

Sanofi Dips Into Red-Hot Radiopharma Space With $110M Licensing Deal  BioSpace

Sanofi at VivaTech - Sanofi

Sanofi at VivaTech  Sanofi

Sanofi in talks to sell 50% stake in consumer health business to CD&R - Reuters.com

Sanofi in talks to sell 50% stake in consumer health business to CD&R  Reuters.com

Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal - BioSpace

Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal  BioSpace

Partner Spotlight: The Anderson Lab and Sanofi Spark the Future of mRNA Research - Sanofi

Partner Spotlight: The Anderson Lab and Sanofi Spark the Future of mRNA Research  Sanofi

Caring for Community & Planet: How Sanofi Is Improving Lives While Reducing Its Emissions - Sanofi

Caring for Community & Planet: How Sanofi Is Improving Lives While Reducing Its Emissions  Sanofi

NAACP, Sanofi Announce Groundbreaking Partnership to Advance Health Equity at 115th NAACP Nationa...

NAACP, Sanofi Announce Groundbreaking Partnership to Advance Health Equity at 115th NAACP National Convention  NAACP

Sanofi may have found a buyer for its consumer health business - BioPharma Dive

Sanofi may have found a buyer for its consumer health business  BioPharma Dive

Sanofi reaches deal on terms of sale of consumer health arm, say French government sources - Reuters

Sanofi reaches deal on terms of sale of consumer health arm, say French government sources  Reuters

Digital “Twinning”: Clinical Trials Powered by AI - Sanofi

Digital “Twinning”: Clinical Trials Powered by AI  Sanofi

Sanofi, Denali Abandon Mid-Stage Multiple Sclerosis Study on Disappointing Data - BioSpace

Sanofi, Denali Abandon Mid-Stage Multiple Sclerosis Study on Disappointing Data  BioSpace

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare - GlobeN...

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare  GlobeNewswire

Sanofi profit growth beats market view on early start of vaccine sales - Reuters

Sanofi profit growth beats market view on early start of vaccine sales  Reuters

Sanofi acquires rights to aficamten for hypertrophic cardiomyopathy in Greater China - World Phar...

Sanofi acquires rights to aficamten for hypertrophic cardiomyopathy in Greater China  World Pharmaceutical Frontiers

Sanofi Inks $326M Radiopharma Deal With Orano - BioSpace

Sanofi Inks $326M Radiopharma Deal With Orano  BioSpace

Teva and Sanofi jump on experimental bowel disease drug success - Yahoo Finance

Teva and Sanofi jump on experimental bowel disease drug success  Yahoo Finance

Sanofi’s rare disease drug finds yet another home - BioPharma Dive

Sanofi’s rare disease drug finds yet another home  BioPharma Dive

Sanofi moves ahead with CD&R deal for stake in consumer business - BioPharma Dive

Sanofi moves ahead with CD&R deal for stake in consumer business  BioPharma Dive

Eli Lilly, Novo Nordisk, and Sanofi must make insulin pens available at $1 each - Doctors Without...

Eli Lilly, Novo Nordisk, and Sanofi must make insulin pens available at $1 each  Doctors Without Borders (MSF-USA)

As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals - BioS...

As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals  BioSpace

Sanofi Seals Deal With Private Equity Firm for 50% Stake in Consumer Healthcare Unit - BioSpace

Sanofi Seals Deal With Private Equity Firm for 50% Stake in Consumer Healthcare Unit  BioSpace

Sanofi and Regeneron’s Dupixent Snags First Biologic Approval in COPD - BioSpace

Sanofi and Regeneron’s Dupixent Snags First Biologic Approval in COPD  BioSpace

Sanofi's tolebrutinib drug delays progressive MS by 31% in trial - Reuters.com

Sanofi's tolebrutinib drug delays progressive MS by 31% in trial  Reuters.com

Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung' - Reuters.com

Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'  Reuters.com

Sanofi's mixed fortunes in MS drug trials has market focus on win - Reuters.com

Sanofi's mixed fortunes in MS drug trials has market focus on win  Reuters.com

Amid push to redefine itself, Sanofi names new chief scientific officer - STAT

Amid push to redefine itself, Sanofi names new chief scientific officer  STAT

Sanofi wins US approval for multiple myeloma drug in newly diagnosed patients - Reuters.com

Sanofi wins US approval for multiple myeloma drug in newly diagnosed patients  Reuters.com

Sanofi, Formation and OpenAI design AI tool to slash clinical trial timelines - Fierce Biotech

Sanofi, Formation and OpenAI design AI tool to slash clinical trial timelines  Fierce Biotech

Sanofi, expanding in radiopharma, strikes a joint venture deal - BioPharma Dive

Sanofi, expanding in radiopharma, strikes a joint venture deal  BioPharma Dive

Sanofi’s Tolebrutinib Misses Two of Three Late-Stage Multiple Sclerosis Readouts - BioSpace

Sanofi’s Tolebrutinib Misses Two of Three Late-Stage Multiple Sclerosis Readouts  BioSpace

Sanofi in exclusive talks with CD&R over sale of $17 billion Opella - Reuters

Sanofi in exclusive talks with CD&R over sale of $17 billion Opella  Reuters

Sanofi CEO believes company poised for growth from new drugs - Reuters.com

Sanofi CEO believes company poised for growth from new drugs  Reuters.com

Customer perspective: Sanofi - Everbridge

Customer perspective: Sanofi  Everbridge

Sanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit Opella - Fierce...

Sanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit Opella  FiercePharma

Sanofi lifts 2024 profit forecast on strength in Dupixent, new products - Reuters.com

Sanofi lifts 2024 profit forecast on strength in Dupixent, new products  Reuters.com

Sanofi finds a silver lining in mixed MS drug results - BioPharma Dive

Sanofi finds a silver lining in mixed MS drug results  BioPharma Dive

Shares, Structure & Vote - Sanofi

Shares, Structure & Vote  Sanofi

Sanofi to invest $437 mln in India global centre, double its workforce - Reuters.com

Sanofi to invest $437 mln in India global centre, double its workforce  Reuters.com

Sanofi Gets Binding Bids from CD&R, PAI for Consumer Arm - Bloomberg

Sanofi Gets Binding Bids from CD&R, PAI for Consumer Arm  Bloomberg

Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line - Reuters.com

Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line  Reuters.com

Open letter to Sanofi on barriers to accessing diabetes medicines - MSF Access Campaign

Open letter to Sanofi on barriers to accessing diabetes medicines  MSF Access Campaign

Sanofi Cancels Consumer Healthcare Business Spin-Off - Forbes

Sanofi Cancels Consumer Healthcare Business Spin-Off  Forbes

Sanofi to invest 1.3 bln euros in new insulin plant in Frankfurt - Reuters.com

Sanofi to invest 1.3 bln euros in new insulin plant in Frankfurt  Reuters.com

Regeneron and Sanofi’s Dupixent Tipped to Dominate COPD Biologics Market - BioSpace

Regeneron and Sanofi’s Dupixent Tipped to Dominate COPD Biologics Market  BioSpace

Recordati buys rights to rare immune disorder drug from Sanofi for $825 mln - Reuters.com

Recordati buys rights to rare immune disorder drug from Sanofi for $825 mln  Reuters.com

From consumer health to pure biopharma: Inside Sanofi’s strategic shift - Labiotech.eu

From consumer health to pure biopharma: Inside Sanofi’s strategic shift  Labiotech.eu

A Global Living Wage employer - Sanofi

A Global Living Wage employer  Sanofi

Sanofi NextGen Scholars - Sanofi

Sanofi NextGen Scholars  Sanofi

Sanofi Drives Modernization with Vault Quality - Veeva

Sanofi Drives Modernization with Vault Quality  Veeva

All in on AI, Environmentally Responsible - Sanofi

All in on AI, Environmentally Responsible  Sanofi

FDA, after delay, clears Regeneron and Sanofi drug for COPD - BioPharma Dive

FDA, after delay, clears Regeneron and Sanofi drug for COPD  BioPharma Dive

Press Release: Sanofi, RadioMedix, and Orano Med announce - GlobeNewswire

Press Release: Sanofi, RadioMedix, and Orano Med announce  GlobeNewswire

Sanofi gets two bids valuing its consumer health unit at about $17 billion, Bloomberg News report...

Sanofi gets two bids valuing its consumer health unit at about $17 billion, Bloomberg News reports  Reuters.com

Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply - Reuters.com

Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply  Reuters.com

Sanofi sees promise in a pill for inflammatory conditions - Drug Discovery News

Sanofi sees promise in a pill for inflammatory conditions  Drug Discovery News

Sanofi eyes investment of up to $1.6 bln in Germany, Handelsblatt says - Reuters.com

Sanofi eyes investment of up to $1.6 bln in Germany, Handelsblatt says  Reuters.com

Sanofi Global Health Unit: making a difference for our patients in low- and middle-income countri...

Sanofi Global Health Unit: making a difference for our patients in low- and middle-income countries  Sanofi

Sanofi Sues Sarepta Over Elevidys DMD Gene Therapy, Alleges Patent Infringement - BioSpace

Sanofi Sues Sarepta Over Elevidys DMD Gene Therapy, Alleges Patent Infringement  BioSpace